Targepeutics
PrivateLast Round
Seed
Jul 24, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Targepeutics operates in Healthcare & Life Sciences and is based in Hummelstown, Pennsylvania. Its latest recorded funding round was a Seed round in July 2025.
Targepeutics is a biopharmaceutical company that develops selective molecularly targeted immunotoxin therapies for the treatment of aggressive brain cancers, including glioblastoma and diffuse midline glioma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Targepeutics Comparables
Compare Targepeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mesenkia Therapeutics AB | 78% | |
| MimiVax Inc. | 78% | |
| Mustang Bio Inc | 77% |
For institutional investors. Book with your work email.
Targepeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 24, 2025 | ||||
| Grant | Sep 12, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Targepeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Yuvaan Tiwari Foundation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 40% MoM, reaching 1.7K.
- Apr 7, 2026
Monthly visitors increased 102% MoM.
For institutional investors. Book with your work email.
Targepeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Targepeutics's valuation, stock price, and market status.
Is Targepeutics a public or private company?
Targepeutics is a private company.
What is the current stock price of Targepeutics?
Targepeutics is a private company, so its shares have no public market price. Caplight tracks Targepeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Targepeutics worth (valuation)?
Valuation information for Targepeutics is not publicly available.
Can I buy Targepeutics stock?
Targepeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Targepeutics's last funding round?
Targepeutics's most recent funding round was Seed on July 24, 2025.
Who are the main investors in Targepeutics?
Key investors in Targepeutics include National Cancer Institute, Yuvaan Tiwari Foundation.
Will Targepeutics IPO soon?
No public IPO plans have been announced for Targepeutics.
How can I track Targepeutics secondary market activity?
Caplight tracks bids, offers, and trades in Targepeutics's shares on secondary markets.